Clinical Trial Update: Retrospective Observational Study to Define HBsAg Loss With or Without Seroconversion to antiHBs in Patients With Chronic Hepatitis by B Virus Treated With Nucleoside/Nucleotide Analogs

View source ↗

Summary

A retrospective observational study to define HBsAg loss with or without seroconversion to anti-HBs in patients with chronic hepatitis B treated with nucleoside…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Snippet

Sponsor: Fundación Pública Andaluza Progreso y Salud | Conditions: Chronic Hepatitis B Treated With Nucleoside/Nucleotide Analogues | Status: COMPLETED